Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Patient Characteristics
3.2. Comparison of Primary Headache Characteristics by Age Groups
3.3. Comparison of Secondary Headache Characteristics by Age Groups
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1204–1222. [Google Scholar] [CrossRef] [PubMed]
- Antonaci, F.; Voiticovschi-Iosob, C.; Di Stefano, A.L.; Galli, F.; Ozge, A.; Balottin, U. The evolution of headache from childhood to adulthood: A review of the literature. J. Headache Pain 2014, 15, 15. [Google Scholar] [CrossRef] [PubMed]
- Gassmann, J.; Vath, N.; van Gessel, H.; Kröner-Herwig, B. Risk factors for headache in children. Dtsch. Arztebl. Int. 2009, 106, 509–516. [Google Scholar] [PubMed]
- Anttila, P.; Metsähonkala, L.; Sillanpää, M. Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics 2006, 117, e1197–e1201. [Google Scholar] [CrossRef]
- Jacobsena, B.A.; Dyb, G.; Hagen, K.; Stovner, L.J.; Holmen, T.L.; Zwart, J.A. The Nord-Trøndelag Health Study shows increased prevalence of primary recurrent headaches among adolescents over a four-year period. Scand. J. Pain 2018, 2, 148–152. [Google Scholar] [CrossRef]
- Roser, T.; Bonfert, M.; Ebinger, F.; Blankenburg, M.; Ertl-Wagner, B.; Heinen, F. Primary versus secondary headache in children: A frequent diagnostic challenge in clinical routine. Neuropediatrics 2013, 44, 34–39. [Google Scholar]
- Burton, L.J.; Quinn, B.; Pratt-Cheney, J.L.; Pourani, M. Headache etiology in a pediatric emergency department. Pediatr. Emerg. Care 1997, 13, 1–4. [Google Scholar] [CrossRef]
- Conicella, E.; Raucci, U.; Vanacore, N.; Vigevano, F.; Reale, A.; Pirozzi, N.; Valeriani, M. The child with headache in a pediatric emergency department. Headache 2008, 48, 1005–1011. [Google Scholar] [CrossRef]
- Scagni, P.; Pagliero, R. Headache in an Italian pediatric emergency department. J. Headache Pain 2008, 9, 83–87. [Google Scholar] [CrossRef]
- GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18, 459–480. [Google Scholar] [CrossRef]
- Arruda, M.A.; Bigal, M.E. Behavioral and emotional symptoms and primary headaches in children: A population-based study. Cephalalgia 2012, 32, 1093–1100. [Google Scholar] [CrossRef]
- Onofri, A.; Olivieri, L.; Silva, P.; Bernassola, M.; Tozzi, E. Correlation between primary headaches and learning disabilities in children and adolescents. Minerva Pediatr. 2022, 74, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Falla, K.; Kuziek, J.; Mahnaz, S.R.; Noel, M.; Ronksley, P.E.; Orr, S.L. Anxiety and depressive symptoms and disorders in children and adolescents with migraine: A systematic review and meta-analysis. JAMA Pediatr. 2022, 176, 1176–1187. [Google Scholar] [CrossRef] [PubMed]
- Powers, S.W.; Coffey, C.S.; Chamberlin, L.A.; Ecklund, D.J.; Klingner, E.A.; Yankey, J.W.; Peugh, J.L.; Korbee, L.L.; Simmons, K.; Sullivan, S.M.; et al. Prevalence of headache days and disability 3 years after participation in the childhood and adolescent migraine prevention medication trial. JAMA Netw. Open 2021, 4, e2114712. [Google Scholar] [CrossRef] [PubMed]
- Singhi, S.; Jacobs, H.; Gladstein, J. Pediatric headache: Where have we been and where do we need to be. Headache 2014, 54, 817–829. [Google Scholar] [CrossRef]
- Babineau, S.E.; Green, M.W. Headaches in children. Continuum 2012, 18, 853–868. [Google Scholar] [CrossRef]
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018, 38, 1–211. [Google Scholar] [CrossRef]
- Abu-Arafeh, I.; Howells, R. Primary headaches in children under the age of 7 years. Curr. Pain Headache Rep. 2014, 18, 401. [Google Scholar] [CrossRef]
- Wager, J.; Hirschfeld, G.; Zernikow, B. Tension-type headache or migraine? Adolescents’ pain descriptions are of little help. Headache 2013, 53, 322–332. [Google Scholar] [CrossRef]
- Guidetti, V.; Galli, F.; Fabrizi, P.; Giannantoni, A.S.; Napoli, L.; Bruni, O.; Trillo, S. Headache and psychiatric comorbidity: Clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998, 18, 455–462. [Google Scholar] [CrossRef]
- Foiadelli, T.; Piccorossi, A.; Sacchi, L.; De Amici, M.; Tucci, M.; Brambilla, I.; Marseglia, G.L.; Savasta, S.; Verrotti, A. Clinical characteristics of headache in Italian adolescents aged 11-16 years: A cross-sectional questionnaire school-based study. Ital. J. Pediatr. 2018, 44, 44. [Google Scholar] [CrossRef] [PubMed]
- Al-Hashel, J.Y.; Ahmed, S.F.; Alroughani, R. Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents: A Community Based Study. Front. Neurol. 2019, 10, 793. [Google Scholar] [CrossRef] [PubMed]
- Langdon, R.; DiSabella, M.T. Pediatric Headache: An Overview. Curr. Probl. Pediatr. Adolesc. Health Care 2017, 47, 44–65. [Google Scholar] [CrossRef]
- Robberstad, L.; Dyb, G.; Hagen, K.; Stovner, L.J.; Holmen, T.L.; Zwart, J.A. An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT study. Neurology 2010, 75, 712–717. [Google Scholar] [CrossRef]
- Martami, F.; Jayedi, A.; Shab-Bidar, S. Primary headache disorders and body mass index categories: A systematic review and dose-response meta-analysis. Headache 2022, 62, 801–810. [Google Scholar] [CrossRef]
- Cancello, R.; Clément, K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006, 113, 1141–1147. [Google Scholar] [CrossRef]
- Schmidt, F.M.; Weschenfelder, J.; Sander, C.; Minkwitz, J.; Thormann, J.; Chittka, T.; Mergl, R.; Kirkby, K.C.; Faßhauer, M.; Stumvoll, M.; et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS ONE 2015, 10, e0121971. [Google Scholar] [CrossRef] [PubMed]
- Cao, H. Adipocytokines in obesity and metabolic disease. J. Endocrinol. 2014, 220, T47–T59. [Google Scholar] [CrossRef]
- Conti, P.; D’Ovidio, C.; Conti, C.; Gallenga, C.E.; Lauritano, D.; Caraffa, A.; Kritas, S.K.; Ronconi, G. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines. Eur. J. Pharmacol. 2019, 844, 87–94. [Google Scholar] [CrossRef]
- Domínguez, C.; Vieites-Prado, A.; Pérez-Mato, M.; Sobrino, T.; Rodríguez-Osorio, X.; López, A.; Campos, F.; Martínez, F.; Castillo, J.; Leira, R. Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study. Cephalalgia 2018, 38, 904–911. [Google Scholar] [CrossRef]
- Recober, A.; Goadsby, P.J. Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect. 2010, 23, 112–117. [Google Scholar] [CrossRef] [PubMed]
- Abu-Arafeh, I.; Razak, S.; Sivaraman, B.; Graham, C. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev. Med. Child Neurol. 2010, 52, 1088–1097. [Google Scholar] [CrossRef] [PubMed]
- Orr, S.L. Headache in Children and Adolescents. Continuum 2024, 30, 438–472. [Google Scholar] [CrossRef]
- Park, E.G.; Yoo, I.H. The diagnostic values of red flags in pediatric patients with headache. Brain Dev. 2022, 44, 512–519. [Google Scholar] [CrossRef]
- Ahmed, M.A.S.; Ramseyer-Bache, E.; Taylor, K. Yield of brain imaging among neurologically normal children with headache on wakening or headache waking the patient from sleep. Eur. J. Paediatr. Neurol. 2018, 22, 797–802. [Google Scholar] [CrossRef]
- Walter, S.M.; Laderman, M.; Polk, P. Pediatric Headache Attributed to Infection. Semin. Pediatr. Neurol. 2021, 40, 100923. [Google Scholar] [CrossRef]
- Lewis, D.W.; Qureshi, F. Acute headache in children and adolescents presenting to the emergency department. Headache 2000, 40, 200–203. [Google Scholar] [CrossRef] [PubMed]
- Abend, N.S.; Younkin, D.; Lewis, D.W. Secondary headaches in children and adolescents. Semin. Pediatr. Neurol. 2010, 17, 123–133. [Google Scholar] [CrossRef]
- Blaauw, B.A.; Dyb, G.; Hagen, K.; Holmen, T.L.; Linde, M.; Wentzel-Larsen, T.; Zwart, J.A. Anxiety, depression and behavioral problems among adolescents with recurrent headache: The Young-HUNT study. J. Headache Pain 2014, 15, 38. [Google Scholar] [CrossRef]
- Ali, M.W.; Musami, U.B.; Sa’ad, F.K.; Omoaghe, C.; Danimoh, M.A.; Ayoola, Y.A.; Kanu, A.O. Profile of migraine patients in a developing country: A multicentre study. SN Compr. Clin. Med. 2020, 2, 1153–1157. [Google Scholar] [CrossRef]
Number of Patients (n = 3374) | |
---|---|
Male, n (%) | 1593 (47.2%) |
Age (years) at initial visit, median (IQR) | 11 (7–14) |
Types of headaches | |
Primary headaches (n = 2667, 79.0%) | |
Migraine without aura | 993 (37.2%) |
Migraine with aura | 147 (5.5%) |
Tension-type headache | 474 (17.8%) |
Unclassified | 1053 (39.5%) |
Secondary headaches (n = 707, 21.0%) | |
Cranial and cervical vascular disorder (n = 13, 1.8%) | |
Moyamoya disease | 5 (38.5%) |
Arteriovenous malformation | 2 (15.4%) |
Cavernous malformation | 2 (15.4%) |
Cerebral aneurysm | 1 (7.7%) |
Internal carotid artery agenesis | 1 (7.7%) |
Reversible cerebral vasoconstriction syndrome | 1 (7.7%) |
MELAS | 1 (7.7%) |
Non-vascular intracranial disorder (n = 13, 1.8%) | |
Brain tumor | 10 (76.9%) |
Chiari malformation | 2 (15.4%) |
Idiopathic intracranial hypertension | 1 (7.7%) |
Infection (n = 625, 88.4%) | |
Upper respiratory tract infection | 294 (47.0%) |
Lower respiratory tract infection | 3 (0.5%) |
Acute gastroenteritis | 170 (27.2%) |
Urinary tract infection | 2 (0.3%) |
Central nervous system infection | 124 (19.8%) |
Fever without a focus | 32 (5.1%) |
Disorder of homeostasis (n = 5, 0.7%) | |
Disorder of the cranium, neck, eyes, ears, nose, sinuses | |
teeth, mouth, other facial or cervical structure (n = 39, 5.5%) | |
Psychiatric disorder (n = 12, 1.7%) |
Primary Headaches (n = 2667) | Secondary Headaches (n = 707) | p Value | |
---|---|---|---|
Male, n (%) | 1209 (45.3%) | 384 (54.3%) | <0.001 |
Age (years) at initial visit, median (IQR) | 11 (8–14) | 8 (5–12) | |
Age at initial visit | <0.001 | ||
Preschool age (≤6 years) | 434 (16.3%) | 265 (37.5%) | <0.001 |
Children (7–12 years) | 1163 (43.6%) | 280 (39.6%) | 0.056 |
Adolescent (13–18 years) | 1070 (40.1%) | 162 (22.9%) | <0.001 |
Clinical course | <0.001 | ||
Acute (≤3 months) | 816 (30.6%) | 659 (93.2%) | |
Acute recurrent (≤3 months) | 530 (19.9%) | 22 (3.1%) | |
Chronic (>3 months) | 375 (14.1%) | 7 (1.0%) | |
Chronic progressive (>3 months) | 943 (35.4%) | 19 (2.7%) | |
Mixed | 3 (0.1%) | 0 | |
Localization | <0.001 | ||
Diffuse | 422 (15.8%) | 78 (11.0%) | |
Localized | 2010 (75.4%) | 273 (38.6%) | |
Mixed | 235 (8.8%) | 356 (50.4%) | |
Duration | <0.001 | ||
<10 min | 320 (12.0%) | 25 (3.5%) | |
10–<30 min | 308 (11.5%) | 24 (3.4%) | |
30–<60 min | 376 (14.1%) | 29 (4.1%) | |
≥1 h | 1663 (62.4%) | 629 (89.0%) | |
Frequency | 0.015 | ||
<2/month | 261 (9.8%) | 56 (7.9%) | 0.131 |
2–<4/month | 468 (17.5%) | 117 (16.5%) | 0.533 |
4–<15/month | 869 (32.6%) | 231 (32.7%) | 0.964 |
≥15/month | 807 (30.3%) | 253 (35.8%) | 0.005 |
Daily | 262 (9.8%) | 50 (7.1%) | 0.025 |
Pain intensity | <0.001 | ||
Mild | 547 (20.5%) | 72 (10.2%) | <0.001 |
Moderate | 1638 (61.4%) | 577 (81.6%) | <0.001 |
Severe | 482 (18.1%) | 58 (8.2%) | <0.001 |
Headache awakening from sleep at night | 503 (18.9%) | 66 (9.3%) | <0.001 |
Headache on or soon after waking up in the morning | 736 (27.6%) | 58 (8.2%) | <0.001 |
Character | <0.001 | ||
Throbbing | 808 (30.3%) | 57 (8.1%) | <0.001 |
Sharp | 112 (4.2%) | 18 (2.5%) | 0.042 |
Cramping | 27 (1.0%) | 4 (0.6%) | 0.375 |
Prickling | 254 (9.5%) | 30 (4.2%) | <0.001 |
Constant/dull | 133 (5.0%) | 25 (3.5%) | 0.105 |
Pressure | 626 (23.5%) | 91 (12.9%) | <0.001 |
Mixed | 189 (7.1%) | 473 (66.9%) | <0.001 |
Others | 518 (19.4%) | 9 (1.3%) | <0.001 |
Associated symptoms | 1757 (65.9%) | 523 (74.0%) | <0.001 |
Nausea/vomiting | 1167 (43.8%) | 415 (58.7%) | <0.001 |
Abdominal pain | 172 (6.4%) | 85 (12.0%) | <0.001 |
Photophobia | 398 (14.9%) | 17 (2.4%) | <0.001 |
Phonophobia | 432 (16.2%) | 23 (3.3%) | <0.001 |
Dizziness | 804 (30.1%) | 81 (11.5%) | <0.001 |
Nasal symptoms | 106 (4.0%) | 98 (13.9%) | <0.001 |
Presence of neurologic abnormalities * | 415 (15.6%) | 32 (4.5%) | <0.001 |
Gait disturbance | 4 (0.1%) | 2 (0.3%) | 0.612 |
Focal weakness | 55 (2.1%) | 6 (0.8%) | 0.031 |
Visual disturbance | 295 (11.1%) | 18 (2.5%) | <0.001 |
Hearing impairment | 19 (0.7%) | 1 (0.1%) | 0.098 |
Dysarthria/aphasia | 11 (0.4%) | 2 (0.3%) | 1.00 |
Dysesthesia | 51 (1.9%) | 4 (0.6%) | 0.011 |
Decreased consciousness | 27 (1.0%) | 5 (0.7%) | 0.662 |
Seizure | 6 (0.2%) | 1 (0.1%) | 1.00 |
Movement symptom † | 25 (0.9%) | 0 | 0.005 |
Triggers | 577 (21.6%) | 24 (3.4%) | <0.001 |
Emotional stress | 376 (14.1%) | 13 (1.8%) | <0.001 |
Hunger | 12 (0.4%) | 2 (0.3%) | 0.747 |
Weather | 89 (3.3%) | 6 (0.8%) | <0.001 |
Fatigue | 131 (4.9%) | 8 (1.1%) | <0.001 |
Exercise | 74 (2.8%) | 2 (0.3%) | <0.001 |
Light | 22 (0.8%) | 1 (0.1%) | 0.067 |
Noise | 23 (0.9%) | 1 (0.1%) | 0.043 |
Smell | 31 (1.2%) | 0 | 0.001 |
Neuroimaging | |||
Performed | 1325 (49.7%) | 159 (22.5%) | <0.001 |
Computed tomography | 94 (7.1%) | 54 (34.0%) | |
Magnetic resonance imaging | 1231 (92.9%) | 105 (66.0%) | |
Family history of migraine | 831 (31.2%) | 32 (4.5%) | <0.001 |
Preschool, School-Aged Children (n = 1597) | Adolescents (n = 1070) | p Value | |
---|---|---|---|
Male, n (%) | 812 (50.8%) | 397 (37.1%) | <0.001 |
Age (years) at initial visit, median (IQR) | 9 (6–11) | 15 (14–16) | |
Body mass index | <0.001 | ||
<18.5 | 608 (38.1%) | 166 (15.5%) | <0.001 |
18.5–<24.9 | 846 (53.0%) | 696 (65.0%) | <0.001 |
≥25 | 143 (9.0%) | 208 (19.4%) | <0.001 |
Types of headaches | <0.001 | ||
Migraine without aura | 480 (30.1%) | 513 (47.9%) | <0.001 |
Migraine with aura | 51 (3.2%) | 96 (9.0%) | <0.001 |
Tension-type headache | 294 (18.4%) | 180 (16.8%) | 0.293 |
Unclassified | 772 (48.3%) | 281 (26.3%) | <0.001 |
Clinical course | <0.001 | ||
Acute (≤3 months) | 551 (34.5%) | 265 (24.8%) | <0.001 |
Acute recurrent (≤3 months) | 339 (21.2%) | 191 (17.9%) | 0.032 |
Chronic (>3 months) | 193 (12.1%) | 182 (17.0%) | <0.001 |
Chronic progressive (>3 months) | 513 (32.1%) | 430 (40.2%) | <0.001 |
Mixed | 1 (0.1%) | 2 (0.2%) | 0.568 |
Localization | <0.001 | ||
Diffuse | 226 (14.2%) | 196 (18.3%) | 0.004 |
Localized | 1201 (75.2%) | 809 (75.6%) | 0.812 |
Mixed | 170 (10.6%) | 65 (6.1%) | <0.001 |
Duration | <0.001 | ||
<10 min | 247 (15.5%) | 73 (6.8%) | <0.001 |
10–<30 min | 213 (13.3%) | 95 (8.9%) | <0.001 |
30–<60 min | 238 (14.9%) | 138 (12.9%) | 0.145 |
≥1 h | 899 (56.3%) | 764 (71.4%) | <0.001 |
Frequency | 0.036 | ||
<2/month | 285 (17.8%) | 227 (21.2%) | 0.030 |
2–<4/month | 289 (18.1%) | 223 (20.8%) | 0.078 |
4–<15/month | 434 (27.2%) | 265 (24.8%) | 0.165 |
≥15/month | 424 (26.5%) | 253 (23.6%) | 0.091 |
Daily | 165 (10.3%) | 102 (9.5%) | 0.500 |
Pain intensity | <0.001 | ||
Mild | 415 (26.0%) | 132 (12.3%) | <0.001 |
Moderate | 947 (59.3%) | 691 (64.6%) | 0.006 |
Severe | 235 (14.7%) | 247 (23.1%) | <0.001 |
Character | <0.001 | ||
Throbbing | 365 (22.9%) | 443 (41.4%) | <0.001 |
Sharp | 76 (4.8%) | 36 (3.4%) | 0.078 |
Cramping | 18 (1.1%) | 9 (0.8%) | 0.470 |
Prickling | 193 (12.1%) | 61 (5.7%) | <0.001 |
Constant/dull | 92 (5.8%) | 41 (3.8%) | 0.025 |
Pressure | 359 (22.5%) | 267 (25.0%) | 0.140 |
Mixed | 74 (4.6%) | 115 (10.7%) | <0.001 |
Others | 420 (26.3%) | 98 (9.2%) | <0.001 |
Headache awakening from sleep at night | 259 (16.2%) | 244 (22.8%) | <0.001 |
Headache on or soon after waking up in the morning | 400 (25.0%) | 336 (31.4%) | <0.001 |
Associated symptoms | 964 (60.4%) | 793 (74.1%) | <0.001 |
Nausea/vomiting | 604 (37.8%) | 563 (52.6%) | <0.001 |
Abdominal pain | 116 (7.3%) | 56 (5.2%) | 0.036 |
Photophobia | 191 (12.0%) | 207 (19.3%) | <0.001 |
Phonophobia | 180 (11.3%) | 252 (23.6%) | <0.001 |
Dizziness | 432 (27.1%) | 373 (34.9%) | <0.001 |
Nasal symptoms | 81 (5.1%) | 25 (2.3%) | <0.001 |
Presence of neurologic abnormalities * | 163 (10.2%) | 252 (23.6%) | <0.001 |
Gait disturbance | 3 (0.2%) | 1 (0.1%) | 0.653 |
Focal weakness | 21 (1.3%) | 34 (3.2%) | <0.001 |
Visual disturbance | 117 (7.3%) | 178 (16.6%) | <0.001 |
Hearing impairment | 7 (0.4%) | 12 (1.1%) | 0.040 |
Dysarthria/aphasia | 6 (0.4%) | 5 (0.5%) | 0.718 |
Dysesthesia | 23 (1.4%) | 28 (2.6%) | 0.030 |
Decreased consciousness | 7 (0.4%) | 20 (1.9%) | <0.001 |
Seizure | 2 (0.1%) | 4 (0.4%) | 0.227 |
Movement symptom † | 5 (0.3%) | 20 (1.9%) | <0.001 |
Triggers | 318 (19.9%) | 259 (24.2%) | 0.008 |
Emotional stress | 195 (12.2%) | 181 (16.9%) | <0.001 |
Hunger | 8 (0.5%) | 4 (0.4%) | 0.772 |
Weather | 56 (3.5%) | 33 (3.1%) | 0.552 |
Fatigue | 74 (4.6%) | 57 (5.3%) | 0.417 |
Exercise | 43 (2.7%) | 31 (2.9%) | 0.752 |
Light | 15 (0.9%) | 7 (0.7%) | 0.425 |
Noise | 8 (0.5%) | 15 (1.4%) | 0.014 |
Smell | 14 (0.9%) | 17 (1.6%) | 0.093 |
Treatment | |||
Analgesics (acetaminophen, ibuprofen) | 1151 (72.1%) | 977 (91.3%) | <0.001 |
Triptans | 2 (0.1%) | 32 (3.0%) | <0.001 |
Prophylaxis | 61 (3.8%) | 166 (15.5%) | <0.001 |
Flunarizine | 18 (29.5%) | 102 (61.4%) | |
Amitriptyline | 23 (37.7%) | 50 (30.1%) | |
Propranolol | 4 (6.6%) | 33 (19.9%) | |
Topiramate | 25 (41.0%) | 39 (23.5%) | |
Others | 1 (1.6%) | 11 (6.6%) | |
Neuroimaging | |||
Performed | 715 (44.8%) | 610 (57.0%) | <0.001 |
Computed tomography | 32 (2.0%) | 62 (10.2%) | |
Magnetic resonance imaging | 683 (42.8%) | 548 (89.8%) | |
Family history of migraine | 513 (32.1%) | 318 (29.7%) | 0.189 |
Preschool, School-Aged Children (n = 545) | Adolescents (n = 162) | p Value | |
---|---|---|---|
Male, n (%) | 302 (55.4%) | 82 (50.6%) | 0.282 |
Age (years) at initial visit, median (IQR) | 7 (5–10) | 15 (13–16) | |
Types of headaches | <0.001 | ||
Cranial and cervical vascular disorder | 7 (1.3%) | 6 (3.7%) | 0.044 |
Non-vascular intracranial disorder | 8 (1.5%) | 5 (3.1%) | 0.178 |
Infection | 495 (90.8%) | 130 (80.2%) | <0.001 |
Disorder of homeostasis | 2 (0.4%) | 3 (1.9%) | 0.082 |
Disorder of the cranium, neck, eyes, ears, | 30 (5.5%) | 9 (5.6%) | 0.980 |
nose, sinuses, teeth, mouth, other facial or | |||
cervical structure | |||
Psychiatric disorder | 3 (0.6%) | 9 (5.6%) | <0.001 |
Clinical course | <0.001 | ||
Acute (≤3 months) | 518 (95.0%) | 141 (87.0%) | <0.001 |
Acute recurrent (≤3 months) | 16 (2.9%) | 6 (3.7%) | 0.621 |
Chronic (>3 months) | 3 (0.6%) | 4 (2.5%) | 0.052 |
Chronic progressive (>3 months) | 8 (1.5%) | 11 (6.8%) | <0.001 |
Localization | <0.001 | ||
Diffuse | 49 (9.0%) | 29 (17.9%) | 0.001 |
Localized | 191 (35.0%) | 82 (50.6%) | <0.001 |
Mixed | 305 (56.0%) | 51 (31.5%) | <0.001 |
Duration | 0.219 | ||
<10 min | 17 (3.1%) | 8 (4.9%) | |
10–<30 min | 15 (2.8%) | 9 (5.6%) | |
30–<60 min | 22 (4.0%) | 7 (4.3%) | |
≥1 h | 491 (90.1%) | 138 (85.2%) | |
Frequency | 0.580 | ||
<2/month | 72 (13.2%) | 27 (16.7%) | |
2–<4/month | 71 (13.0%) | 19 (11.7%) | |
4–<15/month | 188 (34.5%) | 52 (32.1%) | |
≥15/month | 166 (30.5%) | 45 (27.8%) | |
Daily | 48 (8.8%) | 19 (11.7%) | |
Pain intensity | 0.016 | ||
Mild | 58 (10.6%) | 14 (8.6%) | 0.460 |
Moderate | 451 (82.8%) | 126 (77.8%) | 0.151 |
Severe | 36 (6.6%) | 22 (13.6%) | 0.005 |
Character | <0.001 | ||
Throbbing | 33 (6.1%) | 24 (14.8%) | <0.001 |
Sharp | 14 (2.6%) | 4 (2.5%) | 1.00 |
Cramping | 4 (0.7%) | 0 | 0.579 |
Prickling | 20 (3.7%) | 10 (6.2%) | 0.165 |
Constant/dull | 15 (2.8%) | 10 (6.2%) | 0.038 |
Pressure | 46 (8.4%) | 45 (27.8%) | <0.001 |
Mixed | 5 (0.9%) | 4 (2.5%) | 0.128 |
Others | 408 (74.9%) | 65 (40.1%) | <0.001 |
Headache awakening from sleep at night | 47 (8.6%) | 19 (11.7%) | 0.233 |
Headache on or soon after waking up in the morning | 39 (7.2%) | 19 (11.7%) | 0.063 |
Associated symptoms | 399 (73.2%) | 124 (76.5%) | 0.396 |
Nausea/vomiting | 321 (58.9%) | 94 (58.0%) | 0.843 |
Abdominal pain | 69 (12.7%) | 16 (9.9%) | 0.339 |
Photophobia | 9 (1.7%) | 8 (4.9%) | 0.016 |
Phonophobia | 13 (2.4%) | 10 (6.2%) | 0.017 |
Dizziness | 42 (7.7%) | 39 (24.1%) | <0.001 |
Nasal symptoms | 77 (14.1%) | 21 (13.0%) | 0.706 |
Presence of neurologic abnormalities * | 13 (2.4%) | 19 (11.7%) | <0.001 |
Gait disturbance | 2 (0.4%) | 0 | 1.00 |
Focal weakness | 3 (0.6%) | 3 (1.9%) | 0.137 |
Visual disturbance | 5 (0.9%) | 13 (8.0%) | <0.001 |
Hearing impairment | 0 | 1 (0.6%) | 0.229 |
Dysarthria/aphasia | 0 | 2 (1.2%) | 0.052 |
Dysesthesia | 2 (0.4%) | 2 (1.2%) | 0.227 |
Decreased consciousness | 2 (0.4%) | 3 (1.9%) | 0.082 |
Seizure | 1 (0.2%) | 0 | 1.00 |
Movement symptom † | 0 | 0 | |
Triggers | 11 (2.0%) | 13 (8.0%) | <0.001 |
Emotional stress | 5 (0.9%) | 8 (4.9%) | <0.001 |
Hunger | 1 (0.2%) | 1 (0.6%) | 0.406 |
Weather | 3 (0.6%) | 3 (1.9%) | 0.137 |
Fatigue | 3 (0.6%) | 5 (3.1%) | 0.018 |
Exercise | 0 | 2 (1.2%) | 0.052 |
Light | 0 | 1 (0.6%) | 0.229 |
Noise | 1 (0.2%) | 0 | 1.00 |
Smell | 0 | 0 | |
Neuroimaging | |||
Performed | 103 (18.9%) | 56 (34.6%) | <0.001 |
Computed tomography | 39 (7.2%) | 15 (26.8%) | |
Magnetic resonance imaging | 64 (11.7%) | 41 (73.2%) | |
Family history of migraine | 20 (3.7%) | 12 (7.4%) | 0.045 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Park, E.G.; Han, S.B.; Lee, J.; Kim, J.M.; Han, J.Y. Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea. Brain Sci. 2024, 14, 951. https://doi.org/10.3390/brainsci14100951
Park EG, Han SB, Lee J, Kim JM, Han JY. Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea. Brain Sciences. 2024; 14(10):951. https://doi.org/10.3390/brainsci14100951
Chicago/Turabian StylePark, Eu Gene, Seung Beom Han, Jin Lee, Jee Min Kim, and Ji Yoon Han. 2024. "Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea" Brain Sciences 14, no. 10: 951. https://doi.org/10.3390/brainsci14100951
APA StylePark, E. G., Han, S. B., Lee, J., Kim, J. M., & Han, J. Y. (2024). Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in Korea. Brain Sciences, 14(10), 951. https://doi.org/10.3390/brainsci14100951